Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lalic

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|May 22, 2002
Relation between course of disease in type 1 diabetes and islet cell antibodiesM Zamaklar, A Jotic, N Lalic, et al.
Acta Chirurgica Iugoslavica|May 6, 2006
Determination of biochemical relapse after radical prostatectomy by biological detection limit (BDL) after cystoprostatectomy using two PSA assaysJ Hadzi-Djokic, N Lalic, Z Dzamic, et al.
The Journal of Clinical Investigation|September 26, 1997
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)E Ferrannini, A Natali, P Bell, et al.
International Journal of Endocrinology|July 13, 2018
Diabetic Microvascular ComplicationsI Migdalis, L Czupryniak, N Lalic, et al.
Journal of Diabetes Research|November 14, 2017
The Diabetic FootI Migdalis, L Czupryniak, N Lalic, et al.
Acta Chirurgica Iugoslavica|May 6, 2006
The possibilities of age reference values of PSA density in prostatic cancer screeningM Acimovic, Z Dzamic, C Tulic, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2016
Insulin resistance and β-cell function in smokers: results from the EGIR-RISC European multicentre studyM Gottsäter, B Balkau, M Hatunic, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2022
Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicinesAna N Stjepanovic, Nemanja B Todorovic, Tamara Z Tesic, et al.
Diabetologia|August 19, 2009
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trialD Russell-Jones, A Vaag, O Schmitz, et al.
Drug Development and Industrial Pharmacy|December 13, 2025
Deoxycholic acid as a permeability enhancer of two antidiabetic drugs with distinctive biopharmaceutical properties through biological barriersMladena N Lalic-Popovic, Velibor M Vasovic, Nemanja B Todorovic, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|May 22, 2002
Relation between course of disease in type 1 diabetes and islet cell antibodiesM Zamaklar, A Jotic, N Lalic, et al.
Acta Chirurgica Iugoslavica|May 6, 2006
Determination of biochemical relapse after radical prostatectomy by biological detection limit (BDL) after cystoprostatectomy using two PSA assaysJ Hadzi-Djokic, N Lalic, Z Dzamic, et al.
The Journal of Clinical Investigation|September 26, 1997
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)E Ferrannini, A Natali, P Bell, et al.
International Journal of Endocrinology|July 13, 2018
Diabetic Microvascular ComplicationsI Migdalis, L Czupryniak, N Lalic, et al.
Journal of Diabetes Research|November 14, 2017
The Diabetic FootI Migdalis, L Czupryniak, N Lalic, et al.
Acta Chirurgica Iugoslavica|May 6, 2006
The possibilities of age reference values of PSA density in prostatic cancer screeningM Acimovic, Z Dzamic, C Tulic, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2016
Insulin resistance and β-cell function in smokers: results from the EGIR-RISC European multicentre studyM Gottsäter, B Balkau, M Hatunic, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2022
Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicinesAna N Stjepanovic, Nemanja B Todorovic, Tamara Z Tesic, et al.
Diabetologia|August 19, 2009
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trialD Russell-Jones, A Vaag, O Schmitz, et al.
Drug Development and Industrial Pharmacy|December 13, 2025
Deoxycholic acid as a permeability enhancer of two antidiabetic drugs with distinctive biopharmaceutical properties through biological barriersMladena N Lalic-Popovic, Velibor M Vasovic, Nemanja B Todorovic, et al.
Pageof 2